1. Home
  2. ZVRA vs CCIX Comparison

ZVRA vs CCIX Comparison

Compare ZVRA & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • CCIX
  • Stock Information
  • Founded
  • ZVRA 2006
  • CCIX 2023
  • Country
  • ZVRA United States
  • CCIX United States
  • Employees
  • ZVRA N/A
  • CCIX N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • ZVRA Health Care
  • CCIX
  • Exchange
  • ZVRA Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • CCIX 388.3M
  • IPO Year
  • ZVRA 2015
  • CCIX 2024
  • Fundamental
  • Price
  • ZVRA $12.34
  • CCIX $10.53
  • Analyst Decision
  • ZVRA Strong Buy
  • CCIX
  • Analyst Count
  • ZVRA 9
  • CCIX 0
  • Target Price
  • ZVRA $23.25
  • CCIX N/A
  • AVG Volume (30 Days)
  • ZVRA 1.0M
  • CCIX 154.6K
  • Earning Date
  • ZVRA 08-12-2025
  • CCIX 01-01-0001
  • Dividend Yield
  • ZVRA N/A
  • CCIX N/A
  • EPS Growth
  • ZVRA N/A
  • CCIX N/A
  • EPS
  • ZVRA N/A
  • CCIX 0.34
  • Revenue
  • ZVRA $40,588,000.00
  • CCIX N/A
  • Revenue This Year
  • ZVRA $292.31
  • CCIX N/A
  • Revenue Next Year
  • ZVRA $78.65
  • CCIX N/A
  • P/E Ratio
  • ZVRA N/A
  • CCIX $30.98
  • Revenue Growth
  • ZVRA 46.47
  • CCIX N/A
  • 52 Week Low
  • ZVRA $5.45
  • CCIX $10.00
  • 52 Week High
  • ZVRA $12.55
  • CCIX $11.66
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 84.06
  • CCIX N/A
  • Support Level
  • ZVRA $8.58
  • CCIX N/A
  • Resistance Level
  • ZVRA $12.37
  • CCIX N/A
  • Average True Range (ATR)
  • ZVRA 0.51
  • CCIX 0.00
  • MACD
  • ZVRA 0.31
  • CCIX 0.00
  • Stochastic Oscillator
  • ZVRA 98.47
  • CCIX 0.00

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: